# The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19

> **NCT04341480** · — · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 305 (actual)

## Conditions studied

- Gynecological Cancer

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT04341480
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2022-12-10
- **Final completion:** 2023-01-10
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2021-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341480, "The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04341480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*